EXCLUSIVE: Oragenics Tells Benzinga Co. Completes Spray Dry Drug Manufacturing And Intranasal Device Filling In Anticipation Of Phase IIa Clinical Trial In Concussed Patients
EXCLUSIVE: Oragenics Tells Benzinga Co. Completes Spray Dry Drug Manufacturing And Intranasal Device Filling In Anticipation Of Phase IIa Clinical Trial In Concussed Patients
獨家報道：oragenics告訴彭卓金公司已完成噴霧乾燥藥物製造和鼻內裝置充填，預計將進行第IIa期腦震盪患者臨床試驗。
EXCLUSIVE: Oragenics Tells Benzinga Co. Completes Spray Dry Drug Manufacturing And Intranasal Device Filling In Anticipation Of Phase IIa Clinical Trial In Concussed Patients
獨家報道：oragenics告訴彭卓金公司已完成噴霧乾燥藥物製造和鼻內裝置充填，預計將進行第IIa期腦震盪患者臨床試驗。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間